Smart inhaler company Adherium announced last week that it has received 510(k) clearance for over-the-counter sales of its inhaler monitoring device for AstraZeneca’s Symbicort aerosol inhaler, called ...

Summary. Primatene Mist inhalers provide temporary relief from mild, intermittent asthma symptoms. They are the only OTC asthma inhaler approved by the FDA to relieve asthma symptoms like wheezing ...

The FDA approved the generic version, Wixela Inhub (fluticasone-salmeterol; Viatris), as the first generic maintenance inhaler for asthma and chronic obstructive pulmonary disease (COPD) in 2019 ...

FRIDAY, Jan. 3, 2025 (HealthDay News) -- For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with ...

Bivolaru S, Constantin A, Vlase CM, et al. COPD Patients’ Behaviour When Involved in the Choice of Inhaler Device. Healthcare . 2023/1. Sivadasan S, Krishnan A, Dhayalan SV, et al.

Crude incidence of first moderate-to-severe COPD exacerbation was 435 and 410 events per 1,000 person-years for the branded and generic groups, respectively, the bulk of which were moderate cases ...

Please use one of the following formats to cite this article in your essay, paper or report: APA. Thomas, Liji. (2024, August 25). Widespread inhaler misuse in COPD patients: Need for training.

In the first half of 2024, several U.S. health care professionals discussed the price of inhalers for patients with COPD on X, formerly Twitter, according to a tracker from Creation Healthcare.In ...

Baldomero AK, Kunisaki KM, Wendt CH, et al. Guideline-discordant inhaler regimens after COPD hospitalization: associations with rurality, drive time to care, and fragmented care - a United States ...

A 2017 study looked at around 2,600 Medicare Part D and Medicare Advantage plans to determine the average out-of-pocket costs for COPD inhalers. Depending on the inhaler type, costs ranged from ...

In the present cohort study, the researchers compared the effectiveness and safety of two single-inhaler triple therapies for COPD — budesonide-glycopyrrolate-formoterol (administered twice ...

If budesonide-formoterol were to become available over the counter (OTC) and used as-needed for mild asthma, it would save lives and cut healthcare costs, according to a computer modeling study ...